Skip to content

← Grade 12 Biology

Exam practice

Every question from the end of every unit, with hints and answers to open. After you check an answer, mark how you did, and come back to the ones you didn’t get.

11 questions

Unit 28 · Microbial Diseases

Printable PDFs

B. Short answer questions

1.

Summarize the risk groups, biosafety levels and hazard groups of microbes or pathogens.

Answer

Risk groups (WHO) sort microbes by whether they cause disease, how serious it is, how easily it spreads and whether treatment and prevention exist:

  • RG-1: unlikely to cause disease in healthy people (Lactobacillus, baker’s yeast).
  • RG-2: can cause disease, not usually serious, with treatment and prevention available, little spread (influenza virus, Candida albicans).
  • RG-3: usually serious disease, with treatment and prevention available (M. tuberculosis, HIV, hepatitis B virus).
  • RG-4: serious, often deadly disease, spreading readily, usually without treatment or vaccine (Ebola, Marburg, Lassa).

Hazard groups (as in the United Kingdom) sort human pathogens the same way: HG-1 unlikely to cause disease; HG-2 can cause disease but unlikely to spread, treatment available; HG-3 severe disease, may spread, treatment usually available; HG-4 severe, likely to spread, usually no treatment.

Biosafety levels describe the laboratory needed: BSL-1 (open bench) for RG-1/HG-1; BSL-2 (coats, gloves, biosafety cabinet) for RG-2/HG-2; BSL-3 (sealed lab, filtered air drawn inward, respirators) for RG-3/HG-3; BSL-4 (separate building, pressurized suits) for RG-4/HG-4.

2.

Describe the epidemiology of influenza: its incidence, distribution, risk factors and control.

Answer
  • Incidence: seasonal flu infects about a billion people a year and kills about 290,000–650,000 (WHO). Pandemics come irregularly, when a new influenza A virus appears: 1918 (about 50 million deaths), 1957, 1968, 2009.
  • Distribution: worldwide. In temperate regions and in Nepal it peaks in winter (in Nepal also in the monsoon); in the tropics it occurs all year. Types A and B cause the yearly epidemics; A also infects birds and pigs.
  • Risk factors for severe flu: age under 5 or over 65, pregnancy, long-term heart, lung (asthma), kidney or liver disease, diabetes, weak immunity, severe obesity, living in care homes.
  • Spread: droplets from coughs and sneezes, within about 2 m; contaminated hands and surfaces. Incubation 1–4 days.
  • Control: a yearly vaccine matched to the circulating strains; hand washing, covering coughs, masks, staying home when ill, avoiding crowds; antiviral drugs (oseltamivir) for high-risk patients; surveillance of new strains in people, birds and pigs.
3.

Write a short note on hepatitis B.

Answer

Hepatitis B is inflammation of the liver caused by the hepatitis B virus (HBV), a small DNA virus (the complete virus is the Dane particle), with surface (HBsAg), core (HBcAg) and e (HBeAg) antigens. It was once called serum hepatitis.

  • Spread: through blood (shared needles, unscreened transfusions, unsterile tools, razors), sexual contact, and from mother to baby at birth. It is 50–100 times more infectious than HIV.
  • Incubation: 30–180 days (average about 75).
  • Symptoms: often none; or fever, tiredness, loss of appetite, nausea, abdominal pain, dark urine, pale stools and jaundice.
  • Course: most adults clear it, but 90% of infected newborns become chronic carriers, at risk of cirrhosis and liver cancer. About 254 million people live with chronic hepatitis B (2022).
  • Diagnosis: blood test for HBsAg.
  • Prevention: the hepatitis B vaccine (in Nepal’s pentavalent at 6, 10 and 14 weeks), which also prevents hepatitis D; screening blood; safe sex; never sharing needles, razors or toothbrushes.
  • Treatment: antivirals (tenofovir, entecavir) control it.
4.

Sum up candidiasis in human beings.

Answer

Candidiasis is a fungal infection by yeasts of the genus Candida, mostly Candida albicans, which normally lives harmlessly on the skin and in the mouth, gut and vagina.

  • Cause: overgrowth when the balance is upset: antibiotics, diabetes, weak immunity (HIV, cancer drugs, steroids), infancy and old age, dentures, warm moist skin folds. It can pass between sexual partners and from mother to baby at birth.
  • Types: cutaneous (red itchy rash in skin folds, diaper rash), vaginal (itching, burning, thick white discharge), oral (thrush: white patches in the mouth), invasive (in the blood and organs, in very ill people), and candida granuloma (chronic, on skin, scalp, mouth and nails).
  • Diagnosis: microscopy (KOH) and culture of a swab; blood culture and mannan antigen tests for invasive infection.
  • Prevention: keeping skin dry, good mouth hygiene, controlling diabetes, using antibiotics only when needed.
  • Treatment: antifungals: clotrimazole or nystatin creams and gels, fluconazole tablets, and drugs given into a vein for invasive candidiasis.
5.

What is immunity? Explain its types.

Answer

Immunity is the body’s ability to resist foreign substances: pathogens and their toxins.

  1. Innate (non-specific) immunity, present from birth, acting at once against any invader, with no memory: physical and anatomical barriers (skin, mucous membranes, sebum), physiological barriers (temperature, low pH, lysozyme, interferons, complement), phagocytes (neutrophils, macrophages) and inflammation (histamine, kinins, prostaglandins).
  2. Acquired (specific, adaptive) immunity, developed after birth against particular antigens, with specificity, diversity, memory and self/non-self recognition:
    • humoral (antibody-mediated): B cells become plasma cells and make antibodies against microbes and toxins in body fluids;
    • cell-mediated: T cells kill infected and cancer cells and direct the response with cytokines.

By how it is obtained, immunity is active (one’s own antibodies, after infection or vaccination; slow to start, long-lasting) or passive (ready-made antibodies from the mother, or injected as antiserum; immediate but short). Each can be natural or artificial.

6.

What are vaccines and vaccination? Describe the types of vaccines.

Answer

A vaccine is a preparation of killed, inactivated or weakened microbes, their parts, their inactivated toxins (toxoids) or the genes for their antigens, which produces immunity to a disease without causing it. Vaccination is giving a vaccine (by injection, by mouth or as a nasal spray) so that the body makes antibodies and memory cells: artificial active immunity.

Types:

  1. Live attenuated: weakened living microbes: OPV, MR/MMR, BCG, rotavirus, yellow fever.
  2. Inactivated: killed whole microbes: IPV, rabies, hepatitis A, whole-cell pertussis, oral cholera.
  3. Toxoid: inactivated toxins: diphtheria, tetanus.
  4. Subunit: only the antigenic parts, often recombinant: hepatitis B, acellular pertussis, HPV, malaria (RTS,S, R21).
  5. Conjugate: bacterial sugar coats joined to a protein: Hib, PCV, TCV.
  6. Nucleic acid: DNA or mRNA coding for an antigen: the mRNA COVID-19 vaccines.

By method, vaccines are also grouped into generations: first (conventional whole-microbe vaccines), second (recombinant, such as hepatitis B), third (DNA and mRNA) and fourth (designed from the microbe’s binding parts).

C. Long answer questions

1.

What is disease? What is a microbial disease? What are risk, hazard and safety levels in terms of microorganisms? Discuss the risk and hazard groups of microorganisms, with the biosafety levels.

Answer

Disease: any departure from health, the WHO’s “complete physical, mental and social well-being”, that causes discomfort, disability or harm. A microbial disease is one caused by microorganisms: pathogens (viruses, bacteria, fungi, protozoa, worms).

A hazard is anything that could cause harm (a culture of a pathogen); risk is the chance that it does (high if spilled, low if sealed away). The biosafety level is the level of containment, building, equipment and practice, that a lab needs to work safely with a microbe, set by its infectivity, the severity of its disease, its transmissibility and the kind of work.

Risk groups (WHO):

  • RG-1: unlikely to cause disease in healthy people; e.g. E. coli K-12, Lactobacillus acidophilus, Bacillus subtilis, Aspergillus niger, Saccharomyces cerevisiae.
  • RG-2: can cause disease, rarely serious, effective treatment and prevention available, limited spread; e.g. influenza and rotavirus, herpes virus, Streptococcus pneumoniae, Candida albicans, Plasmodium vivax, Leishmania donovani, eggs and larvae of flukes, tapeworms and filarial worms.
  • RG-3: usually serious disease, effective treatment and prevention available; e.g. HBV, HCV, HIV, SARS coronavirus, M. tuberculosis, Salmonella Typhi, Yersinia pestis, Blastomyces dermatitidis.
  • RG-4: serious, often deadly disease, spreading readily, usually without effective treatment or prevention; e.g. Ebola, Marburg and Lassa viruses.

Hazard groups (UK): HG-1, unlikely to cause human disease; HG-2, can cause disease, may be a hazard to workers, unlikely to spread, prophylaxis or treatment usually available; HG-3, can cause severe disease, a serious hazard, may spread, prophylaxis or treatment usually available; HG-4, severe disease, a serious hazard, likely to spread, usually no prophylaxis or treatment.

Biosafety levels: BSL-1 for RG-1/HG-1 (open bench, good practice); BSL-2 for RG-2/HG-2 (coats, gloves, biosafety cabinet, limited access, autoclave); BSL-3 for RG-3/HG-3 (sealed lab with double doors, inward filtered air, all work in cabinets, respirators); BSL-4 for RG-4/HG-4 (separate building, own air and waste systems, pressurized suits or glove boxes).

2.

Name the causative agent of HIV/AIDS. Why is it common among people who inject drugs? Which parts or organs of the body are badly affected? Describe the mode of transmission, symptoms and prevention of HIV/AIDS.

Answer

Causative agent: the human immunodeficiency virus (HIV), an enveloped retrovirus with two copies of single-stranded RNA and the enzyme reverse transcriptase; HIV-1 worldwide, HIV-2 mainly in West Africa.

Among people who inject drugs: sharing needles and syringes carries traces of an infected person’s blood straight into the next person’s vein; repeated many times in a group, it spreads HIV quickly (as Nepal’s epidemic showed among people who inject drugs in the 1990s).

Parts affected: HIV infects and destroys helper T (CD4) cells, and also macrophages and dendritic cells, in the blood, lymph nodes and gut lining, so the whole immune system is weakened; in AIDS, opportunistic infections attack the lungs (TB, Pneumocystis pneumonia), mouth and esophagus (candidiasis), gut, brain and skin.

Mode of transmission: unprotected sexual contact (the commonest route); blood (unscreened transfusions, over 90%; shared needles); mother to baby in pregnancy, at birth or by breastfeeding (15–45% without treatment). Not by touch, food, saliva, tears, sweat or mosquitoes.

Symptoms (stages): acute infection 2–6 weeks after (flu-like: fever, rash, sore throat; window period); years without symptoms except swollen lymph nodes; then long fever, diarrhea and weight loss of over 10% (“slim disease”); finally AIDS, with CD4 under 200 per µL and opportunistic infections: TB, pneumonia, candidiasis, cancers.

Prevention: one faithful uninfected partner or condoms; screening blood; never sharing needles; testing pregnant women and treating mothers with HIV; treatment of people with HIV (U = U); PrEP and PEP for people at risk.

3.

Name the causative agent of typhoid. Explain its mode of transmission, symptoms and control measures, and name the parts or organs badly affected in severe cases.

Answer

Causative agent: Salmonella enterica serovar Typhi, a Gram-negative, rod-shaped, flagellated bacterium whose only natural host is the human.

Mode of transmission: the feco-oral (or urino-oral) route: food or water contaminated with the feces or urine of a patient or a healthy carrier; flies carry it to food. Incubation 6–30 days.

Symptoms: a step-ladder fever rising over the first week, severe headache, abdominal pain, tiredness, loss of appetite, nausea and vomiting, constipation or diarrhea, a pulse slow for the fever (relative bradycardia), and rose spots on the trunk in the second week.

Organs badly affected in severe cases: the small intestine (its Peyer’s patches ulcerate, causing bleeding and perforation), the liver and spleen (enlarged, inflamed), the gallbladder (where carriers keep the bacteria), the blood (sepsis) and rarely the brain’s meninges (meningitis).

Control measures: diagnosis by blood culture in the first week (then Widal, stool and urine culture); treatment with antibiotics chosen by sensitivity testing (azithromycin, ceftriaxone); safe drinking water, sanitation and toilets, hand washing, food cooked and eaten hot, finding and treating carriers, health education, and the typhoid conjugate vaccine (in Nepal at 15 months).

4.

Discuss the causes, causative agent, mode of transmission, effects, symptoms and control measures of tuberculosis. Relate DOTS to it.

Answer

Causes and risk factors: infection with TB bacteria, made likelier by overcrowding, poor ventilation, poverty and undernourishment, dusty closed workplaces (carpet and garment factories), HIV, diabetes, smoking and alcohol.

Causative agent: Mycobacterium tuberculosis, a slender, non-motile, non-spore-forming, slow-growing, acid-fast aerobic bacillus with a waxy cell wall; M. bovis causes TB in cattle and can pass in raw milk.

Mode of transmission: air-borne droplet nuclei coughed out by a person with lung TB; infected raw milk. Incubation about 3 weeks to 3 months; many infections stay latent.

Effects: destroys lung tissue, leaving cavities (pulmonary TB); can spread to the lymph nodes, abdomen, spine (Pott’s spine), skin (lupus vulgaris), brain (TB meningitis) and kidneys, or everywhere through the blood (miliary TB).

Symptoms: cough for more than two weeks, blood in sputum, evening fever, night sweats, weight loss, loss of appetite, tiredness, chest pain.

Control measures: early diagnosis (sputum microscopy, GeneXpert, X-ray, Mantoux test); treatment for 6 months, 2 months of isoniazid, rifampicin, pyrazinamide and ethambutol and 4 of isoniazid and rifampicin; ventilated rooms and covering coughs; BCG vaccine at birth; boiled milk; and treating latent TB in people at high risk.

DOTS (directly observed treatment, short-course): a health worker or volunteer watches the patient swallow each dose, free, with sputum checked and every case recorded, so that patients don’t stop when they feel better and breed drug-resistant TB. Nepal began DOTS in 1996 and covered all districts by 2001.

5.

Why is cholera called a microbial, physical, acquired, communicable, pandemic and water-borne disease? Describe its epidemiology, causative agent, causes, mode of transmission, incubation period, signs and symptoms, effects, diagnosis, prevention and control.

Answer
  • Microbial: caused by a microorganism, Vibrio cholerae.
  • Physical: it harms a part of the body, the small intestine, and through dehydration the whole body.
  • Acquired: caught after birth, not inherited.
  • Communicable: it passes from person to person.
  • Pandemic: it has spread across continents seven times since 1817; the seventh pandemic, since 1961, continues.
  • Water-borne: it spreads mainly in water contaminated with feces.

Epidemiology: from the Ganges delta it spread worldwide in 1817; the seventh pandemic began in Indonesia in 1961, reached Africa in 1971 and South America in 1991. About 1.3–4 million cases and 21,000–143,000 deaths a year, in places without safe water; outbreaks in Nepal in the monsoon. Risk factors: poor sanitation, unsafe water, a sick person at home, raw food and seafood, low stomach acid, blood group O.

Causative agent: Vibrio cholerae, a comma-shaped, Gram-negative rod with one polar flagellum (seen by Pacini in 1854, isolated by Koch in 1883–84).

Causes and mode of transmission: the feco-oral route: water or food contaminated with a patient’s feces or vomit; raw shellfish; raw fruit and vegetables.

Incubation period: 12 hours to 5 days.

Signs and symptoms: most infected people have none or mild ones; in others sudden, painless, profuse rice-water diarrhea and vomiting, then dehydration (sunken eyes, dry mouth, loose skin, thirst, little urine, fast irregular pulse, low blood pressure), muscle cramps and shock; in children also drowsiness, fever, convulsions, coma.

Effects: the cholera toxin keeps cyclic AMP high in gut-lining cells, so chloride, sodium and water pour into the gut; complications are low blood sugar, low potassium and kidney failure.

Diagnosis: stool culture; rapid dipstick tests.

Prevention: sanitation and toilets, hand washing, safe drinking water, food cooked and hot, no raw food; oral cholera vaccine in high-risk places and outbreaks, with a booster if needed.

Control and treatment: ORS (Jeevan Jal) at once; IV fluids for severe dehydration; zinc for children; antibiotics (doxycycline, azithromycin) for severe cases; isolating patients’ feces and disinfecting water in outbreaks.